Portfolio Holdings Detail for ISIN IE00BYZK4776
| Stock Name / Fund | iShares Healthcare Innovation UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares IV Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300ZP07LMR36K1T02 |
| ETF Ticker | DRDR(GBX) LSE |
| ETF Ticker | 2B78(EUR) F |
| ETF Ticker | 2B78.DE(EUR) CXE |
| ETF Ticker | DRDR.LS(GBX) CXE |
| ETF Ticker | HEAL.AS(EUR) CXE |
| ETF Ticker | HEAL.LS(USD) CXE |
| ETF Ticker | HEALz(USD) CXE |
| ETF Ticker | HEAL(EUR) ETF Plus |
| ETF Ticker | DRDR.L(GBP) LSE |
Holdings detail for AGEN
| Stock Name | Agenus Inc |
| Ticker | AGEN(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US00847G7051 |
Show aggregate AGEN holdings
News associated with AGEN
- Agenus (NASDAQ:AGEN) Stock Rating Lowered by Wall Street Zen
- Agenus (NASDAQ:AGEN – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report issued on Sunday. AGEN has been the subject of a number of other reports. HC Wainwright raised shares of Agenus from a “neutral” rating to a “buy” rating and […] - 2025-08-19 02:18:57
- Brokerages Set Agenus Inc. (NASDAQ:AGEN) Target Price at $14.00
- Shares of Agenus Inc. (NASDAQ:AGEN – Get Free Report) have received an average rating of “Hold” from the six research firms that are presently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1-year price target […] - 2025-06-12 02:12:57
- Robert W. Baird Forecasts Strong Price Appreciation for Agenus (NASDAQ:AGEN) Stock
- Agenus (NASDAQ:AGEN – Get Free Report) had its target price raised by research analysts at Robert W. Baird from $4.00 to $6.00 in a report released on Wednesday,Benzinga reports. The firm presently has a “neutral” rating on the biotechnology company’s stock. Robert W. Baird’s target price points to a potential upside of 16.28% from the […] - 2025-06-06 02:58:48
- Agenus (NASDAQ:AGEN) Rating Increased to Buy at HC Wainwright
- HC Wainwright upgraded shares of Agenus (NASDAQ:AGEN – Free Report) from a neutral rating to a buy rating in a report released on Wednesday morning, Marketbeat reports. The firm currently has $25.00 price target on the biotechnology company’s stock. Other equities research analysts have also issued reports about the company. Wall Street Zen upgraded Agenus […] - 2025-06-05 05:24:51
- Deutsche Bank AG Raises Stock Holdings in Agenus Inc. (NASDAQ:AGEN)
- Deutsche Bank AG lifted its holdings in shares of Agenus Inc. (NASDAQ:AGEN – Free Report) by 538.4% in the fourth quarter, HoldingsChannel.com reports. The fund owned 61,144 shares of the biotechnology company’s stock after acquiring an additional 51,566 shares during the period. Deutsche Bank AG’s holdings in Agenus were worth $168,000 as of its most […] - 2025-06-03 04:53:05
- Agenus (NASDAQ:AGEN) Price Target Raised to $4.00
- Agenus (NASDAQ:AGEN – Get Free Report) had its price target hoisted by stock analysts at Robert W. Baird from $3.00 to $4.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the biotechnology company’s stock. Robert W. Baird’s price target suggests a potential upside […] - 2025-05-15 02:24:44
- HC Wainwright Reaffirms “Neutral” Rating for Agenus (NASDAQ:AGEN)
- HC Wainwright restated their neutral rating on shares of Agenus (NASDAQ:AGEN – Free Report) in a research note issued to investors on Tuesday,Benzinga reports. A number of other brokerages have also recently commented on AGEN. StockNews.com raised shares of Agenus from a “sell” rating to a “hold” rating in a research note on Friday, March […] - 2025-05-14 04:58:52
- Agenus Inc. (NASDAQ:AGEN) Receives $8.75 Consensus Target Price from Analysts
- Shares of Agenus Inc. (NASDAQ:AGEN – Get Free Report) have been given an average rating of “Hold” by the six research firms that are currently covering the company, Marketbeat reports. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 12 month […] - 2025-04-23 02:16:53
- Financial Contrast: Agenus (NASDAQ:AGEN) vs. Exelixis (NASDAQ:EXEL)
- Exelixis (NASDAQ:EXEL – Get Free Report) and Agenus (NASDAQ:AGEN – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation. Insider & Institutional Ownership 85.3% of Exelixis shares are owned […] - 2025-04-18 03:01:08
- Analysts Set Agenus Inc. (NASDAQ:AGEN) PT at $10.00
- Agenus Inc. (NASDAQ:AGEN – Get Free Report) has earned a consensus rating of “Hold” from the six brokerages that are presently covering the company, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 12 month price objective among analysts […] - 2025-03-04 04:00:51
- Agenus Inc. (NASDAQ:AGEN) Receives $10.00 Average PT from Brokerages
- Agenus Inc. (NASDAQ:AGEN – Get Free Report) has been assigned an average rating of “Hold” from the six ratings firms that are covering the firm, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1-year target price […] - 2025-02-07 04:13:04
- Notable Wednesday Option Activity: LVS, CRM, AGEN
- Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Las Vegas Sands Corp (Symbol: LVS), where a total volume of 27,562 contracts has been traded thus far today, a contract volume which is representative of approxi - 2025-01-29 18:21:39
iShares Healthcare Innovation UCITS ETF USD (Acc) AGEN holdings
| Date | Number of AGEN Shares Held | Base Market Value of AGEN Shares | Local Market Value of AGEN Shares | Change in AGEN Shares Held | Change in AGEN Base Value | Current Price per AGEN Share Held | Previous Price per AGEN Share Held |
|---|
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of AGEN by Blackrock for IE00BYZK4776
Show aggregate share trades of AGEN| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-06-11 | SELL | -97 | 5.160 | 5.410 | 5.385 | USD -522 | 3.16  Loss of -216 on sale |
| 2025-05-30 | SELL | -97 | 3.430 | 3.500 | 3.493 | USD -339 | 3.05 Loss of -43 on sale |
| 2025-05-21 | BUY | 97 | 3.660 | 3.900 | 3.876 | USD 376 | 3.02 |
| 2025-05-14 | SELL | -582 | 3.470 | 3.560 | 3.551 | USD -2,067 | 3.00 Loss of -321 on sale |
| 2025-04-30 | SELL | -97 | 2.890 | 3.080 | 3.061 | USD -297 | 2.99 Loss of -7 on sale |
| 2025-04-28 | SELL | -97 | 3.140 | 3.190 | 3.185 | USD -309 | 2.99 Loss of -19 on sale |
| 2025-04-25 | SELL | -97 | 2.700 | 3.000 | 2.970 | USD -288 | 2.99  Profit of 2 on sale |
| 2025-04-11 | SELL | -582 | 1.700 | 1.720 | 1.718 | USD -1,000 | 3.07 Profit of 789 on sale |
| 2025-04-08 | SELL | -297 | 1.700 | 1.910 | 1.889 | USD -561 | 3.12 Profit of 364 on sale |
| 2025-04-07 | SELL | -198 | 1.840 | 1.850 | 1.849 | USD -366 | 3.13 Profit of 253 on sale |
| 2025-03-31 | SELL | -198 | 1.510 | 1.570 | 1.564 | USD -310 | 3.20 Profit of 323 on sale |
| 2025-03-21 | SELL | -198 | 1.610 | 1.640 | 1.637 | USD -324 | 3.30 Profit of 330 on sale |
| 2025-03-12 | SELL | -99 | 1.870 | 2.100 | 2.077 | USD -206 | 3.43 Profit of 134 on sale |
| 2025-02-28 | SELL | -99 | 2.850 | 2.910 | 2.904 | USD -287 | 3.55 Profit of 64 on sale |
| 2025-02-25 | BUY | 99 | 3.090 | 3.270 | 3.252 | USD 322 | 3.57 |
| 2025-02-20 | SELL | -99 | 3.450 | 3.510 | 3.504 | USD -347 | 3.58 Profit of 8 on sale |
| 2025-02-19 | BUY | 198 | 3.480 | 3.560 | 3.552 | USD 703 | 3.58 |
| 2025-02-18 | BUY | 99 | 3.520 | 3.600 | 3.592 | USD 356 | 3.58 |
| 2025-01-22 | SELL | -99 | 3.660 | 4.150 | 4.101 | USD -406 | 3.59 Loss of -50 on sale |
| 2025-01-17 | SELL | -99 | 3.480 | 3.500 | 3.498 | USD -346 | 3.59 Profit of 9 on sale |
| 2024-12-30 | SELL | -198 | 2.690 | 2.840 | 2.825 | USD -559 | 3.71 Profit of 175 on sale |
| 2024-12-06 | SELL | -91 | 3.580 | 3.610 | 3.607 | USD -328 | 3.73 Profit of 11 on sale |
| 2024-12-04 | SELL | -92 | 3.430 | 3.750 | 3.718 | USD -342 | 3.76 Profit of 4 on sale |
| 2024-12-03 | SELL | -192 | 3.500 | 3.730 | 3.707 | USD -712 | 3.77 Profit of 13 on sale |
| 2024-11-21 | SELL | -99 | 2.860 | 2.880 | 2.878 | USD -285 | 3.95 Profit of 106 on sale |
| 2024-11-20 | SELL | -99 | 2.670 | 2.800 | 2.787 | USD -276 | 4.02 Profit of 122 on sale |
| 2024-11-19 | SELL | -99 | 2.570 | 2.630 | 2.624 | USD -260 | 4.10 Profit of 146 on sale |
| 2024-11-18 | SELL | -396 | 2.630 | 2.890 | 2.864 | USD -1,134 | 4.19 Profit of 527 on sale |
| 2024-11-12 | SELL | -99 | 3.110 | 3.720 | 3.659 | USD -362 | 4.27 Profit of 60 on sale |
| 2024-11-07 | SELL | -99 | 3.930 | 4.300 | 4.263 | USD -422 | 4.32 Profit of 6 on sale |
| 2024-11-05 | SELL | -198 | 4.150 | 4.170 | 4.168 | USD -825 | 4.35 Profit of 35 on sale |
| 2024-10-28 | SELL | -99 | 4.410 | 4.510 | 4.500 | USD -446 | 4.45 Loss of -5 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of AGEN
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 102,864 | 1,106 | 222,017 | 46.3% |
| 2025-09-18 | 88,096 | 0 | 214,335 | 41.1% |
| 2025-09-17 | 110,072 | 100 | 190,236 | 57.9% |
| 2025-09-16 | 38,224 | 0 | 79,610 | 48.0% |
| 2025-09-15 | 66,309 | 100 | 122,726 | 54.0% |
| 2025-09-12 | 96,866 | 0 | 188,019 | 51.5% |
| 2025-09-11 | 80,728 | 0 | 146,496 | 55.1% |
| 2025-09-10 | 245,235 | 8,502 | 461,439 | 53.1% |
| 2025-09-09 | 337,004 | 0 | 580,230 | 58.1% |
| 2025-09-08 | 62,430 | 3,183 | 151,958 | 41.1% |
| 2025-09-05 | 80,500 | 0 | 158,227 | 50.9% |
| 2025-09-04 | 121,891 | 201 | 179,076 | 68.1% |
| 2025-09-03 | 78,687 | 810 | 163,362 | 48.2% |
| 2025-09-02 | 83,333 | 0 | 199,514 | 41.8% |
| 2025-08-29 | 68,449 | 0 | 181,465 | 37.7% |
| 2025-08-28 | 138,563 | 0 | 263,497 | 52.6% |
| 2025-08-27 | 53,531 | 0 | 112,034 | 47.8% |
| 2025-08-26 | 148,067 | 0 | 279,260 | 53.0% |
| 2025-08-25 | 78,761 | 0 | 145,477 | 54.1% |
| 2025-08-22 | 95,579 | 0 | 213,318 | 44.8% |
| 2025-08-21 | 65,268 | 0 | 142,802 | 45.7% |
| 2025-08-20 | 79,124 | 2,250 | 154,737 | 51.1% |
| 2025-08-19 | 61,258 | 1,060 | 138,103 | 44.4% |
| 2025-08-18 | 45,965 | 1 | 99,651 | 46.1% |
| 2025-08-15 | 68,545 | 0 | 188,725 | 36.3% |
| 2025-08-14 | 114,456 | 342 | 300,817 | 38.0% |
| 2025-08-13 | 169,465 | 3,917 | 362,417 | 46.8% |
| 2025-08-12 | 265,635 | 60,947 | 501,785 | 52.9% |
| 2025-08-11 | 175,438 | 18,777 | 390,602 | 44.9% |
| 2025-08-08 | 126,303 | 0 | 277,665 | 45.5% |
| 2025-08-07 | 81,668 | 14,704 | 296,611 | 27.5% |
| 2025-08-06 | 124,689 | 7,162 | 413,649 | 30.1% |
| 2025-08-05 | 92,834 | 500 | 231,312 | 40.1% |
| 2025-08-04 | 78,223 | 77 | 162,358 | 48.2% |
| 2025-08-01 | 31,154 | 302 | 111,874 | 27.8% |
| 2025-07-31 | 101,618 | 0 | 369,366 | 27.5% |
| 2025-07-30 | 118,068 | 2,507 | 245,594 | 48.1% |
| 2025-07-29 | 216,901 | 763 | 507,235 | 42.8% |
| 2025-07-28 | 197,336 | 574 | 700,713 | 28.2% |
| 2025-07-25 | 149,976 | 45 | 487,581 | 30.8% |
| 2025-07-24 | 86,602 | 0 | 246,960 | 35.1% |
| 2025-07-23 | 146,498 | 116 | 347,128 | 42.2% |
| 2025-07-22 | 212,015 | 2,225 | 522,556 | 40.6% |
| 2025-07-21 | 101,816 | 213 | 375,596 | 27.1% |
| 2025-07-18 | 112,207 | 4,097 | 548,424 | 20.5% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.
Copyright Market Footprint Ltd. Privacy Policy